Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    Annexin V
Show Display Options
Rank Status Study
1 Recruiting Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis
Conditions: Endocarditis;   Thrombosis
Intervention: Other: 99mTc-Annexin V-128 SPECT
2 Withdrawn Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise
Conditions: Cardiovascular Disease;   Ischemia-reperfusion Injury;   Postconditioning
Intervention: Procedure: repetitive short ischemia and reperfusion of non dominant fore arm after 10 minute ischemic exercise
3 Unknown  Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
4 Completed The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance
Conditions: AMPD;   Ischemic Tolerance
Interventions: Drug: systemic administration of 99mTc-HYNIC-Annexin A5;   Behavioral: 10 minutes of ischemic handgripping
5 Completed The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.
Conditions: Ischemia-Reperfusion Injury;   The Metabolic Syndrome
Intervention: Drug: rosiglitazone
6 Completed Rosuvastatin and Ischemia Reperfusion
Condition: Ischemia
Intervention: Drug: Rosuvastatin
7 Completed The Effect of Caffeine on Ischemic Preconditioning
Conditions: Caffeine;   Ischemic Preconditioning;   Ischemia-Reperfusion Injury
Interventions: Drug: caffeine;   Drug: Technetium-TC99m-labeled Annexin A5;   Procedure: ten minutes forearm ischemia;   Procedure: ischemic forearm exercise
8 Suspended Opioid Receptors Influence Ischemia-Reperfusion Injury
Condition: Ischemia-Reperfusion Injury
Interventions: Drug: morphine;   Drug: naloxone;   Drug: Technetium-TC99m-labeled Annexin A5;   Procedure: forearm ischemic exercise;   Procedure: ten minute forearm ischemia
9 Completed Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
Conditions: Ischemia Reperfusion Injury;   Cardiovascular Disease
Intervention: Drug: atorvastatin
10 Completed Ischemic Injury and Ischemic Preconditioning in Diabetes
Conditions: Diabetes Mellitus, Insulin-Dependent;   Ischemia-Reperfusion Injury
Interventions: Procedure: Ischemic preconditioning;   Procedure: Forearm ischemic exercise;   Procedure: Annexin A5 scintigraphy;   Drug: Diazoxide;   Drug: glibenclamide;   Drug: adenosine
11 Active, not recruiting DCE-MRI PET Bevacizumab Study in Rectal Cancer
Condition: Rectal Cancer Patients
Intervention: Drug: Bevacizumab 5 mg/kg
12 Not yet recruiting Imaging of periOP Lung Injury
Conditions: Acute Lung Injury;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Radiation: AxV-128/Tc SPECT-CT imaging
13 Not yet recruiting Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Radiation: AxV-128/Tc SPECT-CT imaging
14 Active, not recruiting Acute Kidney Injury Following Paediatric Cardiac Surgery
Condition: Acute Kidney Injury
Intervention: Procedure: cardiac surgery
15 Completed Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
Condition: Head and Neck Cancer
Intervention: Drug: raltegravir and cisplatin
16 Recruiting Application of MACS and Time-lapse Technology in Good-prognosis Patients
Condition: MACS Technique Efficacy
Interventions: Other: MACS;   Other: NO MACS
17 Unknown  Evaluation of Endometrial Stromal Cell Apoptosis in Adenomyosis
Condition: Endometriosis
Intervention:
18 Completed 99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers
Condition: Healthy Adult Volunteers
Intervention: Drug: Kit for the Preparation of 99mTc-rhAnnexin V-128
19 Completed Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
Conditions: Cardiovascular Disease;   Ischemia-Reperfusion Injury
Interventions: Drug: Dipyridamole;   Drug: caffeine
20 Completed Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
Condition: Ischemia Reperfusion Injury
Intervention: Drug: Rosuvastatin

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.